|
|
|
|
|
by tolmasky
304 days ago
|
|
You listed two violations: "Eschew flamebait. Avoid generic tangents." I can understand the first one, but the second I think is debatable. RFK Jr.'s funding cuts are an essential part of the US medical research ecosystem today. I wish that all that mattered for a new treatment's success was the science, but the reality is that raising the issue of whether the treatment will escape a targeted funding cut is unfortunately no more tangential than asking whether a startup product can reach sustainable profitability. |
|
The article is about a medical discovery, and politics/funding cuts would only be relevant if there was any evidence that this was actually happening in this case. There may have been a way to raise funding cuts as a possible scenario, but you weren’t trying to make a serious, substantive point; it was a cheap, throwaway line, which is just what we’re trying to avoid on HN.
Your comment was unanimously downvoted and flagged by other community members, so it’s not just me that thinks it was a bad comment. Please just take the feedback and make an effort to do better in future.